Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene

G Collod-Béroud1, C Béroud, L Adès

  • 1INSERM U383, Hôpital Necker-Enfants Malades, Université René Descartes, Paris V, 149-161 rue de Sèvres, 75743 Paris Cedex 15, France.

Nucleic Acids Research
|January 1, 1997
PubMed

Insights

Mutations in the fibrillin gene (FBN1) cause Marfan syndrome (MFS) and related disorders. While mutations are widespread, neonatal cases show a specific cluster, suggesting localized genotype-phenotype correlations.

Area of Science:

  • Genetics
  • Molecular Biology
  • Connective Tissue Disorders

Background:

  • Fibrillin is a key protein in extracellular microfibrils.
  • Mutations in the fibrillin gene (FBN1) are linked to Marfan syndrome (MFS).
  • FBN1 mutations also cause a range of MFS-related conditions.

Purpose of the Study:

  • To analyze the spectrum of FBN1 mutations.
  • To investigate genotype-phenotype correlations in MFS and related disorders.
  • To update the Marfan database with new entries and functionalities.

Main Methods:

  • Analysis of FBN1 gene mutations.
  • Review of clinical data from Marfan database entries.
  • Software development for database management.

Main Results:

  • FBN1 mutations are typically private, missense, non-recurrent, and distributed throughout the gene.
  • A specific cluster of neonatal mutations is observed between exons 24 and 32.
  • The Marfan database now includes 89 entries with updated software.

Conclusions:

  • FBN1 mutations are the genetic basis for Marfan syndrome and related disorders.
  • A potential genotype-phenotype correlation exists for neonatal mutations.
  • The updated Marfan database serves as a valuable resource for research.

Related Concept Videos